Pulmonary Embolism Identification Solution From RapidAI Scores FDA Clearance

San Mateo, California-based stroke decision support company RapidAI has earned an FDA clearance for its Rapid PE Triage & Notification, a software meant to accelerate identification and strengthen treatment support for the deadly lung artery blockage known as pulmonary embolism (PE). RapidAI is well known for its clinical decision support solutions leveraging AI-enabled imaging software, many of which help doctors...